Axa’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-125,778
Closed -$7.58M 1447
2016
Q2
$7.58M Sell
125,778
-23,228
-16% -$1.32M 0.03% 459
2016
Q1
$6.85M Sell
149,006
-2,407
-2% -$87.3K 0.03% 478
2015
Q4
$7.32M Sell
151,413
-3,183
-2% -$137K 0.03% 461
2015
Q3
$6.57M Sell
154,596
-171,800
-53% -$8.51M 0.03% 490
2015
Q2
$18.6M Hold
326,396
0.07% 266
2015
Q1
$21.1M Buy
326,396
+23,050
+8% +$1.32M 0.09% 247
2014
Q4
$15.1M Buy
303,346
+19,408
+7% +$1.01M 0.06% 308
2014
Q3
$14M Sell
283,938
-48,654
-15% -$2.07M 0.06% 307
2014
Q2
$12.8M Sell
332,592
-13,378
-4% -$451K 0.05% 354
2014
Q1
$11.1M Buy
345,970
+18,016
+5% +$665K 0.05% 360
2013
Q4
$10.5M Buy
327,954
+49,320
+18% +$1.49M 0.05% 372
2013
Q3
$8.35M Sell
278,634
-372,098
-57% -$10.6M 0.04% 399
2013
Q2
$16M Buy
+650,732
New +$16.4M 0.09% 246

Other funds holding MDVN

Axa's MDVN Position: Q3 2016 in Review

Axa sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 125,778 shares — an estimated $7.58M sold.

Axa first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $21.1M in Q1 2015. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Axa reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Axa sold 125,778 MEDIVATION, INC. shares in Q3 2016, an estimated $7.58M.
  • Axa first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 13 quarters.
  • Axa's MEDIVATION, INC. position peaked at $21.1M in Q1 2015.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Axa's 13F filing for Q3 2016, filed 10 Nov 2016.